Ranibizumab

Ranibizumab is used for diabetic eye disease, wet age-related macular degeneration and Macular edema due to retinal vein occlusion.

Ranibizumab is a monoclonal antibody. It works in cancer by stopping the formation of blood vessels that bring oxygen and nutrients to cancerous cells. This may slow the growth and spread of cancer.

Conjunctival hemorrhage, Eye pain, Increased intraocular pressure, Foreign body sensation in eyes, Blurred vision, Nausea, Dry eye, Eye itching, Cataract, Vitreous floaters, Vitreous detachment, Intraocular inflammation, Eye irritation, Increased lacrimation, Eyelid inflammation, Ocular hyperemia, Retinal disorder, Maculopathy, Eye discomfort, Posterior capsule opacification, Injection site hemorrhage, Nasopharyngitis (inflammation of the throat and nasal passages), Anemia (low number of red blood cells), Joint pain, Renal failure, Peripheral neuropathy (tingling and numbness of feet and hand), Gastro-esophageal reflux disease, Hypercholesterolemia (high cholesterol), Bronchitis (inflammation of the airways)